NCT05555199Completed
Injection of 99mTc-nanocolloid and ICG to Identify, Retrieve and Qualify TDLN in Early-stage NSCLC
Injection of 99mTc-nanocolloid and ICG to Identify, Retrieve and Qualify Tumor Draining Lymph Nodes in Early-stage Lung Cancer
Source: ClinicalTrials.gov · Last updated 20 Feb 2025
Brief summary (registry, in English)
The patient wil receive intra- or peritumoral injections of 99mTc-nanocolloid if malignancy is found during a navigation bronchoscopy. A SPECT/CT-scan will be made to image injections sites and sentinel lymph nodes (SLN). If surgery takes place to treat the lung cancer, ICG will be injected and fluorescent lymph nodes will be extensively assessed by a pathologist.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 72 (actual)
- First submitted
- 31 May 2022
- Start date
- 3 Oct 2022
- Primary completion date
- 31 Oct 2024
- Lead sponsor
- Radboud University Medical Center
- Diseases
- Lung cancer
- NCT number
- NCT05555199
What you commit to
- Study type: Interventional
- Participants enrolled: 72
- From 3 Oct 2022 to the primary completion date, 31 Oct 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Known or suspected allergy to 99mTc-nanocolloid or ICG.
Other
- Pregnancy;
- Inability to consent;
Who the study is looking for
- ASA physical status 1-3;
- Lung lesion between 1 and 5 cm;
- Imaging-based disease free lymph nodes (N0);
- Patient is deemed a candidate for definitive lung tissue resection by a thoracic surgeon.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Radboudumc Coordinator of this site? Confirm its status | Nijmegen | Netherlands | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.